AZD1775 in Treating Patients With Advanced Refractory Solid Tumors With CCNE1 Amplification
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Siqing Fu
University of Texas MD Anderson Cancer Center LAO
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- University of Florida Health Science Center - Gainesville
Gainesville, Florida, United States
- University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
- Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- M D Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Jan 2019
- Primary completion
- 31 Oct 2022
- Completion
- 31 Oct 2022
- Last update posted
- 17 Oct 2023
- Registered enrollment
- 31
- Registry id
- NCT03253679
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.